1. Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets. (August 2016) Authors: Timmins, Peter; Desai, Divyakant; Chen, Wei; Wray, Patrick; Brown, Jonathan; Hanley, Sarah Journal: Therapeutic delivery Issue: Volume 7:Number 8(2016) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An industry update: the latest developments in the field of therapeutic delivery. (July 2017) Authors: Timmins, Peter Journal: Therapeutic delivery Issue: Volume 8:Number 7(2017) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An industry update: what are the latest developments in the field of therapeutic delivery? Industry Update: 1st December to 31st December 2016. (April 2017) Authors: Timmins, Peter Journal: Therapeutic delivery Issue: Volume 8:Number 4(2017) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended‐release formulation of an HIV‐1 attachment inhibitor phosphate ester prodrug. Issue 6 (5th April 2013) Authors: Brown, Jonathan; Chien, Caly; Timmins, Peter; Dennis, Andrew; Doll, Walter; Sandefer, Erik; Page, Richard; Nettles, Richard E.; Zhu, Li; Grasela, Dennis Journal: Journal of pharmaceutical sciences Issue: Volume 102:Issue 6(2013:Jun.) Page Start: 1742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost analysis of type 2 diabetes mellitus treatment in economically developed countries. (2nd January 2019) Authors: Ramzan, Sara; Timmins, Peter; Hasan, Syed Shahzad; Babar, Zaheer-Ud-Din Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 19:Number 1(2019) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Editorial: New Generation Therapeutic Modalities. Issue 1 (5th December 2018) Authors: Timmins, Peter Journal: British journal of pharmacy Issue: Volume 3:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extended release of flurbiprofen from tromethamine-buffered HPMC hydrophilic matrix tablets. (21st October 2018) Authors: Pygall, Samuel; Kujawinski, Sarah; Timmins, Peter; Melia, Colin Journal: Pharmaceutical development and technology Issue: Volume 23:Number 9(2018) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms. (December 2013) Authors: Desai, Divyakant; Wang, Jennifer; Wen, Hong; Li, Xuhong; Timmins, Peter Journal: Pharmaceutical development and technology Issue: Volume 18:Number 6(2013) Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Industry Update. (January 2015) Authors: Timmins, Peter Journal: Therapeutic delivery Issue: Volume 6:Number 1(2015) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Industry Update. (September 2014) Authors: Timmins, Peter Journal: Therapeutic delivery Issue: Volume 5:Number 9(2014) Page Start: 969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗